Sankesh Abbhi - 10 Dec 2021 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Reporting relationship: Director
Issuer ticker: BCLI
Reported as of: 10 Dec 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Dec 2021, 19:02:02 UTC
Source filing: View source filing
Reporting owner signature: /s/ Sankesh Abbhi

Key filing fact

Sankesh Abbhi filed Form 4 for BRAINSTORM CELL THERAPEUTICS INC. (BCLI) on 10 Dec 2021.

Key facts

This page summarizes Sankesh Abbhi's Form 4 filing for BRAINSTORM CELL THERAPEUTICS INC. (BCLI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Dec 2021, 19:02.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCLI transaction

Common Stock

Award

Transaction value: $0
Shares: +6,666
Change %: +143%
Price: $0.000000
Shares after: 11,323
Date: 10 Dec 2021
Ownership: Direct
Footnotes: F1

BCLI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,164,530
Date: 10 Dec 2021
Ownership: Abbhi Investments, LLC
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares acquired are shares of restricted stock awarded pursuant to the Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan. The shares of restricted stock vested in 12 consecutive, equal monthly installments commencing on the one month anniversary of April 6, 2021 until fully vested on the 12 month anniversary of April 6, 2021, provided that the Reporting Person remained a member of the Board of Directors of the Issuer on each vesting date.

Footnote F2

Abbhi Investments, LLC is the record owner of these securities. Mr. Sankesh Abbhi is the manager of Abbhi Investments, LLC and maintains sole voting and investment power with respect to common stock and warrants held by Abbhi Investments, LLC.